More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$16.19B
EPS
0.96
P/E ratio
--
Price to sales
3.6
Dividend yield
--
Beta
1.363465
Previous close
$340.81
Today's open
$342.18
Day's range
$333.04 - $342.58
52 week range
$146.20 - $379.63
show more
CEO
James C. Foster
Employees
19700
Headquarters
Wilmington, MA
Exchange
New York Stock Exchange
Shares outstanding
47917467
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
Charles River Laboratories to Present at Jefferies Global Healthcare Conference
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Jefferies Global Healthcare Conference.
Business Wire • 6 hours ago

Ariel Small Cap Value Q3 2026 Portfolio Activity
Bar-code manufacturer Zebra Technologies was the top contributor during the quarter following a strong earnings report and raise to full-year guidance. Norwegian Cruise Line Holdings declined during the quarter as investors focused on weaker yield expectations, uneven booking trends and ongoing execution challenges. During the quarter, we acquired ADI Global Distribution following its spin-off from our existing holding, Resideo Technologies.
Seeking Alpha • Nov 13, 2026

Charles River Strengthens Global Microbial Solutions Network Through Investments in Manufacturing, Customer Support, and Sustainability
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River has announced a series of strategic investments and operational enhancements across its global Microbial Solutions network.
Business Wire • Nov 12, 2026

GMRS vs. CRL: Which Stock Should Value Investors Buy Now?
Investors interested in Medical Services stocks are likely familiar with GMR Solutions Inc. (GMRS) and Charles River Laboratories (CRL). But which of these two stocks offers value investors a better bang for their buck right now?
Zacks Investment Research • Nov 12, 2026

Tigermed to Participate in the Privatization of Frontage Holdings Corporation and Divest Its Overseas Laboratory Services Business
HANGZHOU, China, Nov. 10, 2026 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. (Stock Codes: 300347.SZ / 3347.HK, hereinafter referred to as "Tigermed"), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, today announced its proposal to participate in the privatization of its controlled subsidiary Frontage Holdings Corporation (Stock Code: 1521.HK, hereinafter referred to as "Frontage"), through its wholly-owned subsidiary Hongkong Tigermed Co., Limited.
PRNewsWire • Nov 10, 2026

Charles River Laboratories to Acquire Frontage's Bioanalysis and DMPK Businesses
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Acquire Frontage's Bioanalysis and DMPK Businesses.
Business Wire • Nov 9, 2026

Unlocking Charles River (CRL) International Revenues: Trends, Surprises, and Prospects
Explore how Charles River's (CRL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Zacks Investment Research • Nov 9, 2026

Here's Why Charles River Laboratories (CRL) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Nov 9, 2026

Charles River Laboratories International Q3 Earnings Call Highlights
Charles River Laboratories International NYSE: CRL raised its 2026 revenue and earnings outlook after third-quarter organic revenue growth accelerated to 4.7%, supported by demand for safety assessment and manufacturing testing services.
MarketBeat • Nov 5, 2026

Charles River Laboratories Stock Pulls A Bear Move As Rats And Mice Retreat
Charles River Laboratories fell as researchers in North America pulled back on their spending on small animals used in lab testing.
Investors Business Daily • Nov 4, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Charles River Laboratories International Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.